MEDICALE SAMARO: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MEDICALE SAMARO
Largest movements
- Cash -€169,576
down €169,576 (-70.1%), from €241,775 to €72,199
mainly Contributions, distributions and other (-€145,067) and Other debts (-€136,191)
- Tangible fixed assets +€40,418
up €40,418 (+274%), from €14,738 to €55,156
of which Furniture and vehicles: +€39,508
- Receivables within one year +€14,977
up €14,977 (+228%), from €6,563 to €21,540
- Other debts -€136,191
down €136,191 (-100.0%), from €136,247 to €57
- Tax, wage and social debts +€20,260
up €20,260 (+450%), from €4,500 to €24,760
- Gross operating margin +€12,527
up €12,527 (+6.8%), from €182,923 to €195,450
- Depreciation +€4,764
up €4,764 (+119%), from €4,004 to €8,768
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €265,330 | €149,481 | -€115,849 | -43.7% |
| Fixed assets | 21/28 | €14,738 | €55,156 | +€40,418 | +274% |
| Tangible fixed assets | 22/27 | €14,738 | €55,156 | +€40,418 | +274% |
| Plant, machinery and equipment | 23 | €640 | €350 | -€290 | -45.3% |
| Furniture and vehicles | 24 | €12,638 | €52,146 | +€39,508 | +313% |
| Other tangible fixed assets | 26 | €1,459 | €2,659 | +€1,200 | +82.2% |
| Current assets | 29/58 | €250,592 | €94,325 | -€156,267 | -62.4% |
| Amounts receivable within one year | 40/41 | €6,563 | €21,540 | +€14,977 | +228% |
| Other amounts receivable | 41 | €6,563 | €21,540 | +€14,977 | +228% |
| Cash at bank and in hand | 54/58 | €241,775 | €72,199 | -€169,576 | -70.1% |
| Deferred charges and accrued income | 490/1 | €2,254 | €586 | -€1,668 | -74.0% |
| Total equity and liabilities | 10/49 | €265,330 | €149,481 | -€115,849 | -43.7% |
| Equity | 10/15 | €123,397 | €123,397 | = | 0.0% |
| Contributions | 10/11 | €100 | €100 | = | 0.0% |
| Reserves | 13 | €123,297 | €123,297 | = | 0.0% |
| Distributable reserves | 133 | €123,297 | €123,297 | = | 0.0% |
| Amounts payable | 17/49 | €141,933 | €26,084 | -€115,849 | -81.6% |
| Amounts payable within one year | 42/48 | €141,933 | €26,084 | -€115,849 | -81.6% |
| Trade debts | 44 | €1,185 | €1,267 | +€82 | +6.9% |
| Suppliers | 440/4 | €1,185 | €1,267 | +€82 | +6.9% |
| Taxes, remuneration and social security | 45 | €4,500 | €24,760 | +€20,260 | +450% |
| Taxes | 450/3 | €4,500 | €24,760 | +€20,260 | +450% |
| Other amounts payable | 47/48 | €136,247 | €57 | -€136,191 | -100.0% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €4,004 | €8,768 | +€4,764 | +119% |
| Other operating charges | 640/8 | €387 | €490 | +€102 | +26.4% |
| Gross operating margin | 9900 | €182,923 | €195,450 | +€12,527 | +6.8% |
| Operating profit (loss) | 9901 | €178,532 | €186,193 | +€7,661 | +4.3% |
| Financial income | 75/76B | €87 | €59 | -€28 | -32.6% |
| Recurring financial income | 75 | €87 | €59 | -€28 | -32.6% |
| Financial charges | 65/66B | €344 | €317 | -€27 | -7.7% |
| Recurring financial charges | 65 | €344 | €317 | -€27 | -7.7% |
| Profit (loss) for the period before taxes | 9903 | €178,276 | €185,935 | +€7,659 | +4.3% |
| Income taxes | 67/77 | €42,028 | €40,868 | -€1,161 | -2.8% |
| Profit (loss) for the period | 9904 | €136,247 | €145,067 | +€8,819 | +6.5% |
| Profit (loss) for the period to be appropriated | 9905 | €136,247 | €145,067 | +€8,819 | +6.5% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 26 October 2026 via checked.be.